Forma Therapeutics Holdings Inc. (NASDAQ:FMTX)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Oct 13|
|Day's Range||19.98 - 20.01|
|52 Week Range||0 - 20.01|
About Forma Therapeutics Holdings Inc.
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Its R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need.
Its work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit.
Forma Therapeutics Holdings Inc. dividends
Forma Therapeutics Holdings Inc has a market cap or net worth of $0.96 billion. The enterprise value is $0.
Forma Therapeutics Holdings Inc has 47.85 million shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is 0.0000. Forma Therapeutics Holdings Inc's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 0.0000%. The beta is 0.0000, so Forma Therapeutics Holdings Inc's price volatility has been lower than the market average.
In the last 12 months, Forma Therapeutics Holdings Inc had revenue of $0 and earned $0 in profits. Earnings per share was $.